Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$523M |
| 2 |
Ionis Pharmaceuticals
IONS
|
+$409M |
| 3 |
Alibaba
BABA
|
+$354M |
| 4 |
Illumina
ILMN
|
+$337M |
| 5 |
PayPal
PYPL
|
+$334M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$798M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$539M |
| 3 |
eBay
EBAY
|
+$333M |
| 4 |
Credicorp
BAP
|
+$111M |
| 5 |
Dolby
DLB
|
+$107M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 31.83% |
| 2 | Communication Services | 18.82% |
| 3 | Healthcare | 13.81% |
| 4 | Financials | 12.02% |
| 5 | Technology | 7.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Moody's
MCO
$83.8B
| $522M | 1.02% |
5,312,866
+174,323
| +3% | +$18.5M |
|
27
Martin Marietta Materials
MLM
$32.6B
| $518M | 1.01% |
3,407,542
+17,569
| +0.5% | +$2.84M |
|
28
CarMax
KMX
$8.27B
| $500M | 0.98% |
8,426,906
+377,829
| +5% | +$23.7M |
|
29
Netflix
NFLX
$305B
| $491M | 0.96% |
47,626,800
+318,000
| +0.7% | +$3.42M |
|
30
Workday
WDAY
$41B
| $458M | 0.9% |
6,668,843
+1,582,483
| +31% | +$122M |
|
31
Waters Corp
WAT
$37B
| $458M | 0.9% |
3,872,397
+97,568
| +3% | +$12.3M |
|
32
JD.com
JD
$44.6B
| $451M | 0.88% |
17,293,743
+160,323
| +0.9% | +$4.64M |
|
33
Visa
V
$683B
| $448M | 0.88% |
6,428,361
+66,517
| +1% | +$4.75M |
|
|
WFM
34
DELISTED
Whole Foods Market Inc
WFM
| $437M | 0.86% |
13,831,266
+535,541
| +4% | +$18.9M |
|
|
SPLK
35
DELISTED
Splunk Inc
SPLK
| $427M | 0.83% |
7,720,695
-95,344
| -1% | -$6.23M |
|
|
HAPN
36
Happen Inc
HAPN
$2.37B
| $426M | 0.83% |
6,442,410
+1,335,905
| +26% | +$90.7M |
|
|
BLUE
37
DELISTED
bluebird bio
BLUE
| $409M | 0.8% |
369,302
+83,862
| +29% | +$153M |
|
38
Myriad Genetics
MYGN
$289M
| $401M | 0.78% |
10,686,758
+311,000
| +3% | +$11M |
|
39
EOG Resources
EOG
$77.3B
| $400M | 0.78% |
5,497,268
+147,775
| +3% | +$11.5M |
|
40
C.H. Robinson
CHRW
$17.3B
| $385M | 0.75% |
5,673,428
+169,370
| +3% | +$11.4M |
|
41
Colgate-Palmolive
CL
$71.7B
| $367M | 0.72% |
5,788,968
+87,941
| +2% | +$5.74M |
|
|
EMBJ
42
Embraer S.A. ADS
EMBJ
$12.7B
| $358M | 0.7% |
14,004,509
+1,675,703
| +14% | +$45.6M |
|
43
American Express
AXP
$233B
| $334M | 0.65% |
4,499,735
+54,037
| +1% | +$4.16M |
|
|
XLNX
44
DELISTED
Xilinx Inc
XLNX
| $320M | 0.63% |
7,544,223
+220,997
| +3% | +$9.3M |
|
|
45
Ionis Pharmaceuticals
IONS
$9B
| $319M | 0.62% |
+7,899,383
| New | +$409M |
|
46
RB Global
RBA
$20.9B
| $307M | 0.6% |
11,859,926
+359,573
| +3% | +$9.83M |
|
|
47
PayPal
PYPL
$49.4B
| $289M | 0.57% |
+9,324,681
| New | +$334M |
|
48
Teradyne
TER
$57.2B
| $286M | 0.56% |
15,897,145
+614,149
| +4% | +$11.3M |
|
|
MON
49
DELISTED
Monsanto Co
MON
| $271M | 0.53% |
3,178,870
+55,810
| +2% | +$5.51M |
|
|
50
Credicorp
BAP
$31.4B
| $263M | 0.51% |
2,468,943
-917,134
| -27% | -$111M |
|
Similar funds
Baillie Gifford & Co's Q3 2015 Portfolio in Review
As of Q3 2015, Baillie Gifford & Co held 223 positions worth $51.1B, down 8.1% from $55.6B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Baillie Gifford & Co's Q3 2015 filing shows 18 new, 84 increased, 49 reduced and 15 closed positions. Its largest new stake was Ionis Pharmaceuticals: 7,899,383 shares worth $319M. The largest sale was Amazon, an estimated $798M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 32% of assets, up from 32% a quarter earlier, followed by Communication Services and Healthcare.
- Baillie Gifford & Co's largest Q3 2015 buy was Ionis Pharmaceuticals: 7,899,383 shares worth $319M.
- Baillie Gifford & Co added most to Tesla in Q3 2015, an estimated $523M increase.
- Baillie Gifford & Co's biggest Q3 2015 reduction was Amazon, cutting an estimated $798M.
- Baillie Gifford & Co fully exited Arcos Dorados Holdings in Q3 2015, selling an estimated $44.6M.
- Baillie Gifford & Co's ten largest holdings make up 46% of its $51.1B portfolio in Q3 2015.
- Baillie Gifford & Co opened 18 new positions and closed 15 in Q3 2015.
- Baillie Gifford & Co's portfolio value fell 8.1% quarter-over-quarter to $51.1B.
Based on Baillie Gifford & Co's 13F filing for Q3 2015, filed 5 Nov 2015.